Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer
Clinical trial NCT06143553 · RECRUITING
Trial details
- NCT number
- NCT06143553
- Sponsor
- Shanghai Yizhong Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-25
- Primary completion
- 2025-12-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.